Class,Axioms,Coverage
file:/Users/mostafa/Projects/forget/data/experiment21/gm02305-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/fatigue-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/basal-ganglia-disease,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gene,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/epistaxis-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/piperazines,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindocetaxelcetuximab-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dystonic-disorder,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tc-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeldoxorubicin-hcl-liposome,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/regulation-of-telomerase-activity,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/hypersensitivity-ae,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelepirubicinpegfilgrastim,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cardiac-fibrillation,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/breast-cancer,32,0.0641
file:/Users/mostafa/Projects/forget/data/experiment21/alopecia-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/magnesium-orotate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/isoproterenol,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/uracil,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/nikkajicompounds,5,0.0100
file:/Users/mostafa/Projects/forget/data/experiment21/fenretinidetretinoin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/hepatofalk,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/entropion,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/thioaldehyde,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxellaniquidar,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/enzyme-activity,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bone-anteversion,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/kidney-concentrating-ability,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/doxorubicindocetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/arthralgia-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/ovarian-neoplasms-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tac-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/reserpine--xipamide-oral-tablet,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindocetaxelfluorouracilleucovorin-calcium,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-protein-synthesis-pe,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelirinotecan,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/allergy-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/urodynamics,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-dna-integrity-pe,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/orotic-acid--vitamin-e-oral-capsule,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/short-qt-syndrome,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeloxaliplatin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cdkal1-wt-allele,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/stomatitis-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/ac-followed-by-docetaxeltrastuzumab-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeldoxorubicin-hcl-liposometrastuzumab,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-rna-integrity-pe,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/retinoic-acid-agent,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/abnormal-heart-rate-variability,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/antitumor-drug,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelestramustineexisulind,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/stomach-neoplasms-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/negative-regulation-of-g2-to-m-transition,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelgem-231,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/coyotes,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/asthenia-ae,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelhypericum-perforatum,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/right-ventricular-outflow-tract-tachycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/phenoxypropanolamines,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bevacizumabdocetaxeldoxorubicin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/onygenales-incertae-sedis,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeloblimersen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelcyclophosphamide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatinfenretinidepaclitaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bacteriochlorophyll-c-binding,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/bacterial-proteins,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/supraventricular-arrhythmia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/active-ingredient,7,0.0140
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeltriptorelin-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/zolantidine,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/bevacizumabdocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tandospirone,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/piperidines,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindocetaxelgemcitabine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/azobenzene,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/telomere-formation-via-telomerase,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/azo-compounds,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/soft-tissue-neoplasms-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/orotic-acid-Concept,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/taxane-pocket-binding-agent,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfowlpox-psa-vaccine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity-decreased-efficacy-abnormal,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/meclofenoxatorotate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/carboplatindocetaxelgemcitabine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/diuretic,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfilgrastimtrastuzumabvinorelbine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/carboplatindocetaxelifosfamide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelzd6474,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/anorexia-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelflavopiridol,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/organic-compound,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/cyclophosphamidedocetaxeldoxorubicin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/45-dihydroorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bevacizumabdocetaxelestramustine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/positive-regulation-of-telomerase-activity,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/capecitabinedocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/1--beta-d-erythrofuranosyl-orotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/abnormal-heart-rhythms,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-catalytic-core-complex,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/smiling,5,0.0100
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelifosfamide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02217-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tubulin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindocetaxelfluorouracil,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/orotate,12,0.0240
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-angle-to,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/sinus-bradycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dihydro-5-azaorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/3-methylorotato--12-diaminocyclohexane-platinum--ii-,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bortezomibdocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/doxorubicin-docetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/drug-hypersensitivity-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfilgrastimxr9576,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/-3-methylorotato--12-diaminocyclohexane-palladium--ii-,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/fenretinidetamoxifen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelinfliximab,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelleuprolidetestosterone,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/pertuzumabtrastuzumabdocetaxel-followed-by-fec-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02306-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/transferase-gene,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dystonia-musculorum-deformans,24,0.0481
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindocetaxeltrastuzumab,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/scattered-molecular-aggregate,7,0.0140
file:/Users/mostafa/Projects/forget/data/experiment21/xipamide,10,0.0200
file:/Users/mostafa/Projects/forget/data/experiment21/melanoma-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelestramustinehydrocortisone,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/neutropenia-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxoletoposide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cytochrome-p450-3a7,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dyspnea-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/cytochrome-p450-3a4,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cytochrome-p450-3a5,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/benzothiazoles,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/2-thioisoorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel,245,0.4910
file:/Users/mostafa/Projects/forget/data/experiment21/choline-dehydrocholic-acid-magnesium-orotate-orotic-acid-vitamin-b12-drug-combination,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ac-followed-by-pertuzumabtrastuzumabdocetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/hereditary-disease,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tch-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/negative-regulation-of-angiogenesis,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/onygenales,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-rna-reverse-transcriptase-activity,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/nervous-system-heredodegenerative-disease,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/13-dimethylorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/fluid-retention-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/infection-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelepirubicin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/lung-cancer,36,0.0721
file:/Users/mostafa/Projects/forget/data/experiment21/cetuximabdocetaxelirinotecan,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/template-for-synthesis-of-g-rich-strand-of-telomere-dna-activity,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/substance-with-mouse-metabolite-role,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cardiovascular-system-symptom,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/beta-adrenergic-agonist,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelsulindac,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/pyrimidines,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/atrial-fibrillation,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/reproductive-and-urinary-physiological-phenomena,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity-Concept,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/d-preparations,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeltlk286,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/paroxysmal-tachycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfilgrastimvinorelbine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/deet-Concept,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity-phenotype,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/terms-related-to-social-and-cultural-sciences,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/kavaform,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/methimazole,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/long-qt-syndrome,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/carboplatindocetaxelestramustine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/rash-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/xipamide-Concept,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelvinorelbine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/serotonin-agonist,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ramucirumabdocetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dihydroorotic-acid-hydrazide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelms-209,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ventricular-arrhythmia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/neutropenia-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/pregnancy-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/palpitations,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/pancreatic-neoplasms-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelvincristine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tpf-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bacteriochlorophylls,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/facial-expression,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelvinblastine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/retinoic-acid-receptor,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelestramustinethalidomide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/leukopenia-ae,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/process-quality,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/methylglucamine-orotate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/positive-regulation-of-cell-differentiation,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/antihypertensive-agents,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelsuramin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity-decreased-process-quality-abnormal,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/b-vitamin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cardiac-arrest,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/pertuzumabtrastuzumabdocetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cbr96-doxorubicin-immunoconjugatedocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/negative-regulation-of-mitosis,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/hereditary-degenerative-disease-of-central-nervous-system,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/protein-synthesis-inhibitors-moa,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/rna-directed-dna-polymerase-activity,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/coccidioides-posadasii,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/oroticaciduria,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/non-neoplastic-heart-disorder,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ac-followed-by-docetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/skin-infection-ae,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/binding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/prostate-cancer,38,0.0762
file:/Users/mostafa/Projects/forget/data/experiment21/biological_process,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/tcf-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeldoxorubicintamoxifen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/complete-atrioventricular-block,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/phenomenon,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/anemia-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/non-neoplastic-cardiovascular-disorder,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/orotic-acid-hydrazide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/fenretinide-Concept,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/UMLS_Concept,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/nausea-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/carboplatindocetaxeltrastuzumab,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/diaphysis-of-femur,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/escherichia-coli-metabolite,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/triamterene--xipamide-oral-tablet,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/metabolic-process,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bradycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/2-oxo-1236-tetrahydropyrimidine-46-dicarboxylate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/CHV_Concept,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/gemcitabine-docetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ad5cmv-p53-genedocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/6-thiodihydroorotate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/phosphoribosylation-of-orotate-to-form-oritidine-5-phosphate--omp-,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02307-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/httpsbmi,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelthalidomide,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelgoserelin-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelvandetanib-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/urinary-tract-physiological-phenomena,7,0.0140
file:/Users/mostafa/Projects/forget/data/experiment21/sinus-tachycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/smile,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelestramustinevitaxin-2zoledronate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ventricular-fibrillation,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/antagonic-stress,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfluorouracilleucovorin-calcium,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/antibacterial-agent,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/carcinoma-non-small-cell-lung-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/diarrhea-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/ventricular-tachycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tachycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/thrombocytopenia-ae,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/biological-regulation,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/taxoids,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomere-maintenance-via-telomerase,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/di-isopropylammonium--orotic-acid-oral-tablet,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/fenretinidevitamin-a,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/2-mercapto-5--4-chlorobenzyl-orotic-aldehyde,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-cisplatin-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/5-deoxy-5-fluoroorotidine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dysgeusia-ae,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/thioketone,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/processed-material,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/urine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bone-disease,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity-process-quality-abnormal,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelestramustinemitoxantroneprednisone,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-efficacy,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/pyrimidinemonocarboxylic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/an-9docetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02256-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/irregular-rhythm,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/atrial-flutter,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/orotic-acid-metabolic-process,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/taxane-compound,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeldoxorubicinoblimersen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/supraventricular-tachycardia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/substance-with-escherichia-coli-metabolite-role,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cardiac-arrhythmias,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02255-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeltrastuzumab-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02264-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/translation-process,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/mitosporic-fungi,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/degarelixdocetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/1-methylorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/breast-neoplasms-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/adult,53,0.1062
file:/Users/mostafa/Projects/forget/data/experiment21/abnormal-femoral-neck-morphology,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/deet,8,0.0160
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-occurrence,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/canidae,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/head-and-neck-neoplasms-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/progressive-familial-heart-block-type-ia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelerlotinib,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/abnormality-of-cardiovascular-system-electrophysiology,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeltariquidar,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity,28,0.0561
file:/Users/mostafa/Projects/forget/data/experiment21/vomiting-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelgefitinib,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfluorouracil,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelgeldanamycin-analogue,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelexisulind,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/orotic-acid,59,0.1182
file:/Users/mostafa/Projects/forget/data/experiment21/urinary-tract-physiological-processes,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/1--beta-d-erythrofuranosyl--5-fluoroorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/av-block-first-degree,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/capecitabinedocetaxel-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelgti-2040,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/hereditary-connective-tissue-disorder,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelleuprolide-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/5-fluorodihydrooorotate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeltamoxifen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/av-block-second-degree,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelvitaxin-2,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cdkal1-gene,5,0.0100
file:/Users/mostafa/Projects/forget/data/experiment21/abnormal,11,0.0220
file:/Users/mostafa/Projects/forget/data/experiment21/amifostinecisplatindocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/benzamides,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-carboplatin-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bacteriochlorophyll-c,5,0.0100
file:/Users/mostafa/Projects/forget/data/experiment21/5-aminoorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02304-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/pharmacologic-substance,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/thiocarbonyl-compound,7,0.0140
file:/Users/mostafa/Projects/forget/data/experiment21/decreased-process-quality,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/irregular-heartbeat,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/myalgia-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeldn-101,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/threonylcarbamoyladenosine-trna-methylthiotransferase,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelmitoxantrone,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cyclophosphamidedocetaxeldoxorubicintamoxifen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/carboplatindocetaxelcetuximab-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/deet-topical-spray,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gtx-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/coccidioides-immitis,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/5-fluoroorotic-acid,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/isoindoles,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-gemcitabine-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/celecoxibdocetaxelirinotecan,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/andersen-tawil-syndrome,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/mouse-metabolite,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/metabolite,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelestramustine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/negative-regulation-of-telomerase-activity,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/gm03218-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ad5cmv-p53-genedocetaxeldoxorubicin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/clorprenaline,3,0.0060
file:/Users/mostafa/Projects/forget/data/experiment21/arrhythmia,38,0.0762
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfilgrastimgemcitabine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/capecitabinedocetaxeltipifarnib,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-estramustine-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ciadox,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/coccidioides-Concept,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/organosulfur-compound,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/sulfa-dysurgal,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm03221-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-inhibitor-activity,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm03208-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/neck-of-femur,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/thrombocytopenia-diseasefinding,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/retinoids,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/fenretinide,16,0.0321
file:/Users/mostafa/Projects/forget/data/experiment21/coccidioides,9,0.0180
file:/Users/mostafa/Projects/forget/data/experiment21/internal-medicine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm03211-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/coxa-vara,10,0.0200
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-prednisone-regimen,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/diuretics,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/xipamide-oral-tablet,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/repellent,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dihydroorotate-hydroxylase,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/chemical-entity,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tachyarrhythmia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/dystonic-disorders,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelfowlpox-psa-vaccinesargramostim,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-chemicalingredient,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelmethotrexate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/carboplatindocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/abnormal-electrophysiology-of-sinoatrial-node-origin,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/deuteromycetes,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/spondyloepimetaphyseal-dysplasia-strudwick-type,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/thiocarbonyl-group,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cardiac-related-comorbidity,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/nail-disorder-ae,6,0.0120
file:/Users/mostafa/Projects/forget/data/experiment21/gm02347-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/bacteriochlorophyll,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/febrile-neutropenia-ae,4,0.0080
file:/Users/mostafa/Projects/forget/data/experiment21/diethyltoluamide-topical-spray,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/glomerular-filtration-rate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/ataxia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxolvinblastine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelketoconazole,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/tandospirone-Concept,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/increased-amount,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelgemcitabine,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/gm02551-cell,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/torsion-dystonia,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/oxidation-of--s--dihydroorotate-to-form-orotate,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/thioureas,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/celecoxibdocetaxel,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/heart-contraction,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxel-Concept,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/telomerase-activity-decreased-occurrence-abnormal,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxelepirubicinfilgrastim,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/apoptosis,2,0.0040
file:/Users/mostafa/Projects/forget/data/experiment21/docetaxeltrastuzumab,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/retinoic-acid-receptor-activation,1,0.0020
file:/Users/mostafa/Projects/forget/data/experiment21/cisplatindimesnadocetaxel,1,0.0020
